With regards to T2D and obesity treatments, this underscores the importance of identifying and characterizing new regulatory cofactors of PPARγ, particularly ones such as ZFP407, which impacts both transcriptional regulatory networks as well as adipocyte development and homeostasis. The gene discussed is PPARG; the disease is obesity disorder.